Too bad Martha Stewart and Sam Waksal weren't more patient with their investments in scandal-plagued ImClone Systems Inc. On Monday, the company's share price soared past pre-scandal levels and ...

Speaking to Wall Street analysts last week, Martha Stewart forcefully stated that her controversial $228,000 sale of ImClone stock last December—a day before the company announced bad news about its ...

Speaking to Wall Street analysts last week, Martha Stewart forcefully stated that her controversial $228,000 sale of ImClone stock last December–a day before the company announced bad news about its ...

NEW YORK, Sept 12 (Reuters) - ImClone Systems Inc said on Wednesday it was "pure coincidence" that its new chief executive bought $500,000 worth of company stock just days before the value of the ...

NEW YORK -- Martha Stewart's defense rested today after calling just one witness -- a lawyer who was with her the first time she spoke to investigators about her sale of ImClone Systems stock. The ...

NEW YORK — A federal grand jury indicted Martha Stewart on charges of securities fraud and obstruction of justice Wednesday in an insider stock trading case that could bring big fines and a jail term ...

Shares of ImClone Systems Inc. rose as much as 39 percent on Friday one day after U.S. regulators approved its cancer drug, Erbitux. Subscribe to read this story ad-free Get unlimited access to ...

NEW YORK - Just days after selling her ImClone Systems stock, Martha Stewart said she knew that ImClone CEO Sam Waksal had been trying to dump his shares in the company, a close friend of Stewart ...

NEW YORK -- Former ImClone Systems chief executive Samuel Waksal, whose arrest on insider trading charges has cast suspicion on Martha Stewart, was indicted Wednesday, apparently after attempts to cut ...

NEW YORK — The drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer ...

NEW YORK (CBS.MW) -- ImClone said it would receive a total $6 million in milestone payments as part of its license agreement with Merck KGaA. The payments were triggered when Merck KGaA's submitted ...

It was, in retrospect, a festival of hype emblematic of the boom years, when technology stocks seemed to have nowhere to go but up. Erbitux, a drug from ImClone Systems Inc., was going to ...